Basal calcitonin levels and the response to pentagastrin stimulation in patients after kidney transplantation or on chronic hemodialysis as indicators of medullary carcinoma

Thyroid

Volumn 9, Issue 9, 1999, Pages 943-947

  Kotzmann, H ^a   Schmidt, A ^a   Scheuba, C ^b   Kaserer, K ^a   Watschinger, B ^a   Soregi G ^a   Niederle, B ^b   Vierhapper, H ^a,b  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; PENTAGASTRIN;

ARTICLE; CALCITONIN BLOOD LEVEL; CHRONIC KIDNEY FAILURE; COMORBIDITY; FOLLOW UP; HEMODIALYSIS; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY;

EID: 0032834098     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1999.9.943     Document Type: Article

References (28)

1. Raue, F, Schmid-Gayek H, Ziegler R 1983 Tumor markers in C-cell cancer. Dtsch Med Wochenschr 108:283-286.
2. Raue F, Zinke A, Scherubl H 1992 Regulation of Calcitonin Secretion and Calcitonin Gene Expression. Recent Results in Cancer Research, vol. 125, Heidelberg, Springer Verlag, Berlin, pp 1-18.
3. Calmettes C, Chaventre A, Feingold N, France B, Guliana JM 1989 French Medullary Study Group (GETC). Screening for medullary thyroid cancer in France. A national effort. Henry Ford Hosp Med J 37:120-121.
4. Pacini F, Fontanelli M, Fugazzola L, Elisei R, Romei C, Di Coscio G, Miccoli P, Pinchera A 1994 Routine measurements of serum calcitonin in nodular thyroid disease allows the pre-operative diagnosis of unsuspected sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab 78:826-829.
5. Rieu M, Lane MC, Richard A, Lissak B, Sambort B, Vuong-Ngoc P, Berrod JL, Fombeur JP 1995 Prevalence of sporadic medullary thyroid carcinoma. The importance of routine measurements of serum calcitonin in the diagnostic evaluation of thyroid nodules. Clin Endocrinol (Oxf) 42:453-460.
6. Vierhapper H, Raber W, Biegelmayer C, Kaserer K, Weinhöusel A, Niederle B 1997 Routine measurements of plasma calcitonin in nodular thyroid diseases. J Clin Endocrinol Metab 82:1589-1593.
7. Niccoli P, Brunet P, Roubicek C, Roux F, Baudin F, Lejeune PJ, Berland Y, Conte-Devolx B 1995 Abnormal calcitonin levels and pentagastrin response in patients with chronic renal failure on maintenance hemodialysis. Eur J Endocrinol 132:75-81.
8. Felsenfeld AJ, Machado L, Rodriguez M. 1993 The relationship between serum calcitonin and serum calcium in hemodialysis patients. Am J Kidney Dis 21:292-299.
9. Mulder H, Siberbusch J, Hackeng WH, Koorevaar G, den Ottolander GJ 1982 Enhanced calcitonin release in chronic renal failure depending on the absence of severe secondary hyperparathyroisism. Nephron 31:123-128.
10. Simmons RE, Hjelle JT, Mahoney C, Deftos LJ, Lisker W, Kato P, Rabkin R 1988 Renal metabolism of calcitonin. Am J Physiol 254:F593-600.
11. Silva OL, Becker KL, Shalhoub RJ Snider RH, Bivin LE, Moore CF 1977 Calcitonin levels in chronic renal disease. Nephron 19:12-18.
12. Tomita T, Millard DM. 1992 C-cell hyperplasia in secondary hyperparathyroidism. Histopathology 21:469-474.
13. Gibson WGH, Peng T, Croker BP 1982 Age associated c-cell hyperplasia in the human thyroid. Am J Physiol 106:388-393.
14. Guyetant S, Wion-Barbot N, Rousselet M, Franc B, Bigorgne JC, Saint-Andre JP 1994 C-cell hyperplasia associated with chronic lymphocytic thyroiditis. Hum Pathol 25:514-521.
15. Lindner A, Farewell VR, Sherrad DJ 1981 High incidence of neoplasia in uremic patients receiving long-term hemodialysis. Nephron 27:292-296.
16. Sayegh MH, Carpenter C 1995 Development of malignancy following organ transplantation. In: Rose BD, (ed) Up to Date in Medicine 1995; version 4.1 1995.
17. Escalada J, Teruel JL, Pavon I, Vila T, Navarro J, Varela C 1993 Normal calcitonin response to pentagastrin stimulation in patients with chronic renal failure. Acta Endocrinol 129:39-41.
18. Lisak B, Baudin E, Cohen R, Barbot N, Meyrier A, Niccoli P, Bouyge N, Modigliani E 1998 Pentagastrin testing in patients with renal insufficiency: Normal responsivity of mature calcitonin. Thyroid 8:265-272.
19. Fink M, Weinhäusel A, Niederle B, Haas OA 1996 Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the ret proto-oncogene. Int J Cancer 69:312-316.
20. Rosai J, Caracangiu ML, DeLellis 1992 Atlas of Tumor Pathology: Tumors of the Thyroid Gland, 3rd series. Armed Forces Institute of Pathology, Washington DC: pp 247-258.
21. Kaserer K, Scheuba CH, Neuhold N, Weinhausel A, Vierhapper H, Haas OA, Niederle B 1998 C-cell hyperplasia and medullary carcinoma in patients routinely screened for serum calcitonin. Am J Surg Pathol 22:722-728.
22. Oberbauer R, Banyai S, Schmidt A, Kornek G, Scheithauser W, Mayer G 1996 Serum tumor markers after renal transplantation. Transplantation 62:1506-1509.
23. LiVolsi VA C-cell hyperplasia/neoplasia. 1997 J Clin Endocrinol Metab 82:39-41.
24. Perry A, Molberg K, Albores Saavedra J 1996 Physiologic vs. neoplastic c-cell hyperplasia of the thyroid: Separation of distinct histologic and biologic entities. Cancer 77:750-756.
25. Schröder S, Böcker W, Baisch H, Burk CG, Arps H, Meiners I, Kastendieck H, Heitz PU, Kloppel G 1988 Prognostic factors in medullary thyroid carcinomas. Cancer 61: 806-816.
26. Silva OL, Becker K, Shalhoub RJ, Snider RH, Bivins IE, Moore CF 1977 Calcitonin levels in chronic renal disease. Nephron 19:12-15.
27. Nielsen HE, Christensen CK, Olsen K 1979 Serum calcitonin levels in patients with chronic renal disease. Acta Med Scand 205:619-621.
28. Martinez ME, Miguel JL, Gomez P, Selgas P, Salinas M, Gentil M, Mateos F, Montero JL, Sanchez Sicilia L 1983 Plasma calcitonin concentrations in patients treated with chronic dialysis: differences between hemodialysis and CAPD. Clin Nephrol 19:250-253.